Meanwhile, a higher expression of ALKBH5 was also positively correlated with a favourable prognosis in gastric cancer; however, it was associated with worse clinical outcomes in colorectal cancer and NSCLC [32–34]. Here, ALKBH5 is linked to gastric cancer.